Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Monoclonal antibody to human interleukin-6

EU orphan designation number: EU/3/02/125
Active ingredient: Monoclonal antibody to human interleukin-6
Indication: Treatment of post-transplant lymphoproliferative disorders
Sponsor: EUSA Pharma SAS
3 allée des Séquoias, F-69760 Limonest, France

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/12/2002 Centralised Orphan - Designation EMEA/OD/052/02 (2002)5451 of 18/12/2002
22/01/2008 Other procedure
27/01/2010 Centralised Orphan - Removal of orphan designation from Community Register